Navigation Links
Global Orthobiologics Market is Expected to Reach $7,900.2 Million by 2019, at a CAGR of 6.7% from 2014 to 2019
Date:4/20/2015

FORT WORTH, Texas, April 20, 2015 /PRNewswire/ --

Orthobiologics are substances that are utilized by orthopedic surgeons for healing bone injuries. The orthobiologics market is a rewarding market, which represents a number of growth opportunities for its stakeholders. The global orthobiologics market report defines and segments the concerned market with analysis and forecast of revenue. The global orthobiologics market was valued at $5,712.4 million in 2014, and is projected to reach $7,900.2 million by 2019, at a CAGR of 6.7% from 2014 to 2019.

Browse through the TOC of global orthobiologics market for an in-depth analysis of the industry trends and segments, with help of various tables and figures.

http://www.micromarketmonitor.com/market-report/orthobiologics-reports-3559061506.html

Early buyers will receive 10% customization on this report.  

The changing preference from mechanical to biological implants, accompanied by the rising awareness of orthobiologics is expediting the growth of this market. The orthobiologics market has seen an impressive growth since 2012, owing to increased research and development activities and rising demand for orthobiologics products.

North America contributes the largest market share in the global orthobiologics market, and is slated to grow further due to recent advancements made in the field of orthopedics. On the other hand, Asia is the fastest growing region in the global orthobiologics market by virtue of its exponential aging population as well as rising prevalence of diabetes and obesity.

Inquiry Before Buying @http://www.micromarketmonitor.com/contact/3559061506-inquery_before_buy.html

The global orthobiologics market is segmented on the basis of product, end-user, and geography. According to geographical segmentation, this market is classified into North America, Europe, Asia, and the rest of the world (RoW).

This report provides a comprehensive overview of market share and value chain analysis, in addition to in-depth insights on varied market metrics such as drivers, restraints and upcoming opportunities. The report also presents a competitive landscape and company profiles of key players in the market. Biomet, Inc. (U.S.), Medtronic, Plc. (U.S.), Integra Life Sciences Corporation (U.S.), Stryker Corporation (U.S.), Zimmer, Inc. (U.S.), DePuy Synthes (U.S.), Tornier, Inc. (Netherlands), Nuvasive, Inc. (U.S.), Exactech, Inc. (U.S.), Globus Medical, Inc. (U.S.), and Wright Medical Technology, Inc. (U.S.) are some of the leading players in the global orthobiologics market.

Related Reports: 

The North America Orthobiologics Market was valued at $1,724.5 million in 2014, and is expected to reach $2,493.5 million by 2019 at a CAGR of 7.7% from 2014 to 2019. The North American orthobiologics market has been segmented on the basis of product, end-user, and country. Orthobiologics market comprises products such as bone graft substitutes, stem cell therapy, bone allografts, viscosupplementation, and bone growth factor & spinal stimulation. The market has been further segmented on the basis of end-users into hospitals, Point of Care (POC) testing, and other end users. The North America Orthobiologics market consists of countries such as the U.S., Canada, and Mexico. 

http://www.micromarketmonitor.com/market/north-america-orthobiologics-9077664565.html

Report Subscription: 

MicroMarket Monitor produces exclusive market research reports, based on real-time data to provide better understanding of the dynamic market conditions of the Healthcare. The reports offer in-depth and complete analysis of the regional and country level marketplaces. The research reports for Healthcare industry are updated on quarterly basis and are easily available for purchase through annual subscriptions.  

http://www.micromarketmonitor.com/offerings/subscription

About MicroMarket Monitor: 

MicroMarket Monitor identifies and attends to various unmet needs of different industrial verticals, which include value chain impact analysis. The company publishes about 12000 Market Research Reports on various Micro Markets across the world. The graphical nature and multidimensional analysis of these reports provide advanced Business Intelligence Tools to the clients in that particular target market.

Contact: 
Mr. Chandrasekhar K. 
5601 Bridge Street 
Suite 300 
Fort Worth, TX 76112 
Tel: +1-888-502-0539 
Email: sales@micromarketmonitor.com


'/>"/>
SOURCE MicroMarket Monitor
Copyright©2015 PR Newswire.
All rights reserved

Related biology technology :

1. Global Stem Cells Group to Host Featured Speaker at The Aesthetic Meeting 2015 in Montreal
2. Global Stem Cells Group To Join GTCbio Stem Cell and Regenerative Medicine Summit in Boston, April 27-29, 2015
3. Alise Reicin Joins the Biopharmaceutical Business of Merck KGaA, Darmstadt, Germany as Head of Global Clinical Development
4. SELLAS Life Sciences Group and TrojanTec Sign Exclusive License Agreement for Global Rights on Development and Commercialization of Innovative TR-1 Anti-Cancer Antennapedia Technology
5. SQI Delivers Sqidlite System to Global Pharmaceutical Customer
6. Strand Life Sciences Names Scott Storrer to Expanded Leadership Position of Global President and Introduces U.S. Management Team
7. Agreements & Partnerships, a Key Strategy Adopted by Leading Market Players to Foster their Growth in the Global Oncology Information System Market - MarketsandMarkets
8. Engage Global and Premier Micronutrient Corporation Announce Strategic Partnership
9. Global miRNA Market Outlook to 2018
10. Actinobac Biomed Selected to Present at Cavendish Global Health Impact Forum
11. Report: Global Market for Dialysis Care Nears 90 Billion Dollars
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/11/2019)... ... June 11, 2019 , ... ... from human mesenchymal stem cells (MSC-EV) are able to incorporate into human CD34+ ... a test on mice, MSC-EVs also increased the cells’ ability to lodge into ...
(Date:5/31/2019)... ... 29, 2019 , ... For many years, the primary forms of cancer treatment ... therapies. Advances in immuno-oncology have led to the advent of Chimeric Antigen Receptor T ... cell receptors known as “CARs”. The CAR enables the final product to produce chemicals ...
(Date:5/31/2019)... ... May 30, 2019 , ... World Compliance Seminars today ... 08-09, 2019 in Boston, MA. This peer recommended interactive workshop is always selected ... training will kick off with a compendial treatment of Data Integrity fundamentals. After ...
(Date:5/31/2019)... ... 30, 2019 , ... A study released today in STEM ... the sustained release of human placental stem cell (HPSC)-derived conditioned medium (CM) to ... CM into the injured kidney, where it helped restore function and regenerate injured ...
Breaking Biology Technology:
(Date:6/4/2019)... ... 04, 2019 , ... Harper was three years old when her owners took ... which caused painful osteoarthritis in the joints. She was referred to a veterinary ... The surgical specialist, Dr. Christopher Eich of Southern California Veterinary Specialty Hospital , ...
(Date:6/3/2019)... ... , ... Stay on top of current hot topics through free webinars presented ... webinars is free, so be sure to register today to save your place! Participate ... to see our upcoming webinars: , CLINICAL TRIALS , June 10 – A Novel ...
(Date:5/31/2019)... , ... May 30, 2019 , ... ... testing company, and Mayo Clinic, have documented significant differences in the prevalence of ... and ethnic populations compared to non-Hispanic White women. Results will be presented at ...
Breaking Biology News(10 mins):